KCNE4 Is an Inhibitory Subunit to Kv1.1 and Kv1.3 Potassium Channels  by Grunnet, Morten et al.
Biophysical Journal Volume 85 September 2003 1525–1537 1525
KCNE4 Is an Inhibitory Subunit to Kv1.1 and Kv1.3 Potassium Channels
Morten Grunnet,* Hannne B. Rasmussen,* Anders Hay-Schmidt,y Maiken Rosenstierne,z Dan A. Klaerke,*
Søren-Peter Olesen,* and Thomas Jespersen*
*Department of Medical Physiology, The Panum Institute, University of Copenhagen, DK-2200 Copenhagen N, Denmark;
yDepartment of Anatomy, The Panum Institute, University of Copenhagen, DK-2200 Copenhagen N, Denmark; and
zDepartment of Molecular Pathology, The Panum Institute, University of Copenhagen, DK-2200 Copenhagen N, Denmark
ABSTRACT Kv1 potassium channels are widely distributed in mammalian tissues and are involved in a variety of functions
from controlling the ﬁring rate of neurons to maturation of T-lymphocytes. Here we show that the newly described KCNE4
b-subunit has a drastic inhibitory effect on currents generated by Kv1.1 and Kv1.3 potassium channels. The inhibition is found
on channels expressed heterologously in both Xenopus oocytes and mammalian HEK293 cells. mKCNE4 does not inhibit
Kv1.2, Kv1.4, Kv1.5, or Kv4.3 homomeric complexes, but it does signiﬁcantly reduce current through Kv1.1/Kv1.2 and Kv1.2/
Kv1.3 heteromeric complexes. Confocal microscopy and Western blotting reveal that Kv1.1 is present at the cell surface
together with KCNE4. Real-time RT-PCR shows a relatively high presence of mKCNE4 mRNA in several organs, including
uterus, kidney, lung, intestine, and in embryo, whereas a much lower mRNA level is detected in the heart and in ﬁve different
parts of the brain. Having the broad distribution of Kv1 channels in mind, the demonstrated inhibitory property of KCNE4-
subunits could locally and/or transiently have a dramatic inﬂuence on cellular excitability and on setting resting membrane
potentials.
INTRODUCTION
Voltage-gated Kv potassium channels are involved in
a considerable number of physiological functions including
neuronal excitability, synaptic transmission, and setting
resting membrane potentials (Hille, 2001). Kv channels
comprise a large family of proteins of quite diverse
structural and functional properties and are widely ex-
pressed in both excitable and nonexcitable tissues. Nine
subfamilies of Kv channels (Kv1–9) have been described
in mammals (Hille, 2001; Chandy and Gutman, 1995;
Roeper and Pongs, 1996).
Within the Kv1 (Shaker) subfamily, at least nine a-sub-
units (Kv1.1–Kv1.9) have been described. These are mostly
non- or slowly inactivating with the exception of Kv1.4
and Kv1.7, which are fast inactivating A-type channels
(Baumann et al., 1988; Chandy et al., 1990; Grupe et al.,
1990; Kalman et al., 1998; Stuhmer et al., 1989; Tempel
et al., 1988). The diversity of Kv1 channels is increased
by the fact that all Kv1 subfamily members in vitro have
been found to coassemble into functional channels, result-
ing in mixed biophysical properties (Isacoff et al., 1990;
Ruppersberg et al., 1990). Many of these subunit combina-
tions have also been identiﬁed in native tissue. For example,
in the mammalian brain Kv1 channel a-subunits are
mainly found as heteromultimer complexes, with Kv1.1
and Kv1.2 as the predominant partners in most channel
complexes (Koch et al., 1997; Shamotienko et al., 1997).
Kv1 channels are expressed with high abundancy in the brain
(Grosse et al., 2000; Monaghan et al., 2001; Rhodes et al.,
1997; Sheng et al., 1994; Veh et al., 1995; Wang et al.,
1994), but also outside the CNS, Kv1 channels are found in
both excitable tissue such as heart and smooth muscle, and in
nonexcitable tissue and cell types such as colon, kidney,
endothelial cells, epithelial cells, adipocytes, T-cells, and
granulosa cells (Grunnet et al., 2002b; Grissmer et al., 1990;
Adda et al., 1996; Mason et al., 2002; Dixon and McKinnon,
1994; Ouadid-Ahidouch et al., 1999; Pappone and Ortiz-
Miranda, 1993).
Three different Kvb-subunits, designated Kvb1, Kvb2,
and Kvb3 (notation according to Pongs et al., 1999), have
been found to interact with Kv channels (Heinemann et al.,
1995; Rettig et al., 1994; Leicher et al., 1998). All three Kvb
genes are subject to alternative splicing, resulting in three
subunit subtypes for Kvb1 (Kvb1.1, Kvb1.2, Kvb1.3) and
two subtypes for both Kvb2 (Kvb2.1, Kvb2.2) and Kvb3
(Kvb3.1, Kvb3.2) (Pongs et al., 1999). The presence of the
Kvb-subunits results in signiﬁcant changes in the regulation
of the Kv1 a-subunits. The most pronounced effect is found
for Kvb1.1, since this subunit confers rapid A-type
inactivation to the otherwise noninactivating Kv1.1, Kv1.2,
and Kv1.5 channels (Heinemann et al., 1996). Other
functions, such as increased surface expression of Kv
channels, are also reported for Kvb-subunits (Fink et al.,
1996; Shi et al., 1996).
The KCNE family forms another class of one-trans-
membrane proteins capable of modulating potassium
channels. This family of K1-channel b-subunits consists of
ﬁve members, designated KCNE1–5 (formerly known as
minK, MiRP1–3, and KCNE1-like, respectively), all capable
of modulating the KCNQ1 current in vitro (Abbott et al.,
1999; Piccini et al., 1999; Grunnet et al., 2002a; Angelo et al.,
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2002; Tinel et al., 2000a; Schroeder et al., 2000). KCNE1–3
have furthermore been shown to modulate other members of
the KCNQ family as well as ERG, HCN, and Kv K1
channels (McDonald et al., 1997; Yu et al., 2001; Zhang
et al., 2001; Abbott et al., 1999, 2001; Schroeder et al., 2000;
Tinel et al., 2000b). In a number of cases, currents recorded
from native cells have been shown to be due to speciﬁc
interactions between K1-channel a-subunits and b-subunits
of the KCNE family. Several mutations within KCNE1–3
are associated with serious disease (Abbott et al., 1999,
2001; Splawski et al., 1997). For Kv channels, KCNE3 has
been found to combine with the Kv3.4 a-subunit forming
a subthreshold, A-type channel in skeletal muscle (Abbott
et al., 2001) and KCNE2 assembles with Kv4.2 and is
thereby potentially involved in shaping the Ito current in the
heart or the native A-type currents (Zhang et al., 2001; Kim
et al., 2001).
Until recently, no potential assembly partners of KCNE4
and KCNE5 have been discovered. We have reported
interaction of KCNE4 and KCNE5 with KCNQ1, providing
modulations of the KCNQ1 current (Grunnet et al., 2002a;
Angelo et al., 2002). In the present study we demonstrate
a drastic inhibition of Kv1.1 and Kv1.3 currents by the
KCNE4-subunit in both Xenopus oocytes and mammalian
HEK293 cells. KCNE4 mRNA is found at relative high
levels in several peripheral tissues in which Kv1.1/Kv1.3
channels have also been identiﬁed. The interaction between
KCNE4 and Kv1.1/Kv1.3 may thereby be important in
certain physiological functions. These observations add
to the understanding of the promiscuity of K1-channel
b-subunits and support the idea that K1 currents in native
cells reﬂect a complex interaction between pore-forming
a-subunits and regulatory b-subunits.
METHODS
Molecular biology
cDNA coding for rKv1.1, rKv1.2, rKv1.4, rKv1.5, and hKv4.3 were kindly
provided by O. Pongs. To obtain robust expression in Xenopus laevis
oocytes rKv1.1, rKv1.3, rKv1.5, hKv4.3, and mKCNE4 (accession number
391797, The National Center for Biotechnology Information (NCBI)),
cDNA were subcloned into the oocyte and mammalian expression vector
pXOOM (Jespersen et al., 2002). Kv1.1SYG was generated by overlap
extension PCR altering the GGA codon (Gly) into a TCG codon (Ser) of the
rKv1.1 gene located in the pXOOM-rKv1.1 plasmid. Speciﬁc current could
be obtained from Kv1.2 and Kv1.4 channels expressed from their original
vectors, pAKS2-RCK5 and pAKS2-RCK4, respectively, and these channels
were therefore not subcloned into the pXOOM vector.
For expression in HEK293 cells, the internal ribosome entry site (IRES)
from EMCV (from pIRES-puro, ClonTech, Palo Alto, CA) and either Kv1.1
or Kv1.3 were PCR ampliﬁed, linked together by overlap extension, and
subcloned into the mammalian expression vector pNS2n, a custom-designed
derivative of pcDNA3neo (InVitrogen, Carlsbad, CA) expressing a neo-
EGFP fusion gene, to give pIRES-Kv1.1 and pIRES-Kv1.3. The nucleotide
linker between IRES and KCNQ1 was designed to have an optimal sequence
for initiation of translation (ACACGATAATACCATG) (Morgan et al.,
1992). pKCNE4-Kv1.1 and pKCNE4-Kv1.3 were constructed by inserting
the KCNE4 gene upstream of the IRES element. Usage of an IRES element
for bicistronic expression ensures expression of both KCNE4 and Kv
proteins. The KCNE4-c-myc-tagged protein used in the confocal analyses
was constructed by oligonucleotides and PCR, introducing nucleotides
encoding a c-myc epitop sequence (EQKLISEEDL) in the C-terminal end of
mKCNE4. The integrity of all PCR-generated constructs was conﬁrmed by
sequencing.
In vitro transcription and capping were performed using the mCAP
mRNA capping kit (Stratagene, La Jolla, CA). mRNA was phenol/
chloroform extracted, ethanol precipitated, and dissolved in TE buffer (10
mM TrisCl, 1 mM EDTA, pH 7.5) to a concentration of ;0.1 mg/ml. The
integrity of the transcripts was conﬁrmed by agarose gel electrophoresis, and
mRNA was stored at 808C until injection.
Transient expression in Xenopus oocytes and
HEK293 cells
Xenopus laevis surgery and oocyte treatment were done as previously
described (Grunnet et al., 2001). Oocytes were kept in Kulori medium (90
mMNaCl, 1mMKCl, 1 mMMgCl2, 1 mMCaCl2, 5mMHEPES, pH 7.4) for
24 h at 198C before injection of 50 nl of mRNA (;5 ng). For coexpression of
Kv1- and KCNE4-subunits, cRNA was mixed in a 1:1 molar ratio. Since the
absolute speciﬁc current level of oocytes expressing Kv1.1 and Kv1.3
channels were ;10 times the current level of oocytes expressing Kv1.2
channels, all coexpression studies with Kv1.1 and Kv1.2 or Kv1.3 and Kv1.2
were performed after mRNA injection in a 1:10 ratio. Oocytes were kept at
198C in Kulori medium for 2–7 days before measurements were performed.
HEK293 cells were grown in DMEM (Life Technologies, Carlsbad, CA)
supplemented with 10% FCS (Life Technologies) at 378C, in 5% CO2. One
day before transfection, 2 3 106 cells were plated in a cell culture T75 ﬂask
(Nunc). Cells were transfected with 2 mg of plasmid, using Lipofectamine
(Life Technologies) according to the manufacturer’s instructions. Electro-
physiological studies were performed 48–72 h post transfection.
Electrophysiology
Oocytes. Current was recorded using a two-electrode voltage-clamp
ampliﬁer (Dagan CA-1B, Minneapolis, MN, USA). Electrodes were pulled
from borosilicate glass capillaries on a horizontal patch electrode puller and
had tip resistance between 0.3 and 2.0 MV when ﬁlled with 1 M KCl.
During the experiments oocytes were placed in a small chamber (volume:
200 ml) connected to a continuous ﬂow system (ﬂow: 6 ml/min). Kv1
channels were activated by membrane depolarization, and channel activity
was measured in Kulori solution consisting of (in mM): 90 NaCl, 1 KCl,
1 MgCl2, 1 CaCl2, 5 HEPES; pH was 7.4. All experiments were performed
at room temperature.
HEK293 cells. Experiments were performed in whole-cell patch-clamp
conﬁguration at room temperature with an EPC-9 ampliﬁer (HEKA
Electronics, Lambrecht, Germany). Pipettes were pulled from thin-walled
borosilicate glass and had a resistance between 1.5 and 2.5 MV. A custom-
made perfusion chamber (volume 15 ml) with a ﬁxed AgCl-Ag pellet
electrode was mounted on the stage of an inverted microscope. Coverslips
with transiently transfected HEK293 cells were transferred to the perfusion
chamber and superfused with physiological solutions consisting of (in mM)
150 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2 and 10 HEPES (pH 7.4 with NaOH).
Pipettes were ﬁlled with solutions consisting of (in mM) 144 KCl, 1 EGTA
and 10 HEPES (pH 7.2 with KOH). CaCl2 and MgCl2 were added in
concentrations calculated (EqCal, BioSoft, Cambridge, UK) to give a free
Mg21 concentration of 1 mM and free Ca21 concentrations of 100 nM. Cell
capacitance and series resistance was updated before each pulse application.
Series resistance values were between 2.5 and 10.0 MV, and only
experiments where the resistance remained constant during the experiments
were analyzed. Current signals were low-pass ﬁltered at 3 kHz and acquired
using Pulse software (HEKA Electronics).
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Analysis of electrophysiological data
Data analyses and drawings were performed using IGOR software
(WaveMetrics, Lake Oswego, OR). All values are shown as mean 6 SE.
The degree of signiﬁcance between the differences of two means was
calculated using the t-test.
Fluorescence staining and confocal analysis
Cells were ﬁxed in 4% (w/v) paraformaldehyde in PBS (136 mM NaCl, 2.5
mM KCl, 1.5 mM KH2PO4, 6.5 mM NaHPO4, pH 7.4) for 15 min, washed
in PBS, and quenched for 20 min with 50 mMNH4Cl in PBS. After washing
in PBS, cells were permeabilized with PBS containing 0.1% (w/v) Triton
X-100 and 0.12% (w/v) ﬁsh skin gelatin for 8 min. To reduce nonspeciﬁc
labeling, cells were blocked with 0.25% (w/v) gelatin in PBS for 30 min.
The cells were then exposed to a primary antibody directed against Kv1.1
(1/100 dilution, Alomone Labs, Jerusalem, Israel) or c-myc (1/300 dilu-
tion, Boehringer Mannheim, Basel, Switzerland) for 1 h followed by
incubation with Alexa 488-donkey anti-mouse IgG and Alexa 568-goat anti-
rabbit IgG (1/800 dilutions, Molecular Probes, Leiden, The Netherlands) for
45 min. After washing, the coverslips were mounted in Prolong antifade
(Molecular Probes, Leiden, the Netherlands).
The ﬂuorescent-labeled samples were examined by sequential laser
scanning confocal microscopy using a LEICA TCS SP2 equipped with
argon and helium-neon lasers. The objective was 633, NA1.2. Images were
treated using Metamorph imaging software and Adobe Photoshop 5.5.
Cell surface biotinylation
HEK293 cells. The plasma membrane was labeled using the membrane-
impermeable biotinylation reagent, sulfo-NHS-SS-biotin (Pierce Chemical,
Rockford, IL). Kv1.1/KCNE4-expressing HEK293 cells were rinsed three
times at 48C with PBS (136 mM NaCl, 2.5 mM KCl, 1.5 mM KH2PO4, 6.5
mM NaHPO4, pH 7.4) containing 1 mM CaCl2 and 1 mM MgCl2 (PBS
21)
and washed for 5 min. The buffer was removed, and biotinylation was
performed by incubation in 1 mg/ml sulfo-NHS-SS-biotin in PBS21 for 23
30 min at 48C. The biotinylation was terminated by removal of the medium
and by ﬁve washes (2 min each) in 2 mg/ml BSA in PBS21 at 48C.
Xenopus oocytes
Oocytes injected with KCNQ1 or KCNE4 and KCNQ1 cRNA were rinsed
three times at 48C in Kulori solution and washed for 5 min. The buffer was
removed and biotinylation was performed in 35-mm dishes by incubation in
1.5 mg/ml sulfo-NHS-SS-biotin (Pierce) in Kulori solution for 23 20 min at
48C. The biotinylation was terminated by a 20-min incubation in Kulori
solution containing 100 mM glycine.
Preparation of membranes from
Xenopus oocytes
Membranes from oocytes were prepared as described earlier (Grunnet et al.,
2001). Batches of 50 oocytes injected with KCNQ1, KCNQ1 1 KCNE4 or
noninjected oocytes were homogenized in 10% sucrose dissolved in
homogenization buffer (600 mM KCl, 5 mMMOPS, 100 mM PMSF, 1 mM
pepstatin A, 1 mM p-aminobenzamide, aprotinine (1 mg/ml), and leupeptin
(1 mg/ml), pH 6.8) in a volume of 10 ml/oocyte with 10 strokes at 1000 rpm
in a glass/ Teﬂon homogenizer (Braun-Melsungen) at 08C. The homogenate
was placed on top of a step gradient consisting of 7 ml 50% sucrose and 3.5
ml 20% sucrose in homogenization buffer and centrifuged at 67,0003 g for
30 min at 48C in a Beckman SW 40 rotor. The interface (between 20% and
50% sucrose) was collected and subjected to centrifugation at 84,0003 g for
30 min at 48C in a Beckman Ti 70.1 rotor. The supernatant was discarded
and the pellet resuspended in 200 ml 300 mM sucrose, 100 mM KCl, 5 mM
MOPS, pH 6.8 and stored at 808C until use.
Streptavidin-coupled agarose adsorption
All steps were performed on ice unless otherwise indicated. Extracts of
puriﬁed HEK293/oocyte membranes were diluted in 0.5 vol of a 1:1 slurry
of streptavidin-coupled agarose beads (Sigma, St. Louis, MO) in binding
buffer (1% TX-100, 150 mM NaCl, 5 mM EDTA, 50 mM Tris-HCL, pH
7.5). Samples were incubated overnight at 48C with end-over-end rolling
mixing. The beads were then pelleted by centrifugation for 2 min at 3673 g.
They were washed thrice in binding buffer, twice in binding buffer
containing 0.5 M NaCl, and once in 50 mM Tris, pH 7.5. The pelleted beads
were resuspended in 50 mM Tris, pH 7.5 and Laemmli sample buffer
(0.0625 M Tris, 9.9% glycerol, 2% SDS, 5% beta-mercaptoethanol,
0.00125% bromphenol blue) added. Biotinylated proteins were eluted by
heating for 4 min on a heating block at 1008C and were immediately
collected using a syringe. The eluates were analyzed by SDS-PAGE
followed by immunoblotting.
Western blotting
SDS-PAGE (8% acrylamide) was performed using the Bio-Rad Laboratories
mini-gel system (Hercules, CA). Proteins were transferred onto a hybond-P
PVDF transfer membrane (Amersham Biosciences, Freiburg, Germany,
0.45 mm) in 25 mM Tris base, 200 mM glycine, 20% methanol using a mini-
transblot. After transfer, the membranes were incubated for 1 h at room
temperature in blocking buffer (PBS containing 5% low-fat milk powder and
0.1% Tween-20). The membrane was incubated overnight in blocking buffer
containing an antibody directed against Kv1.1 (1/100 dilution, Alomone
Labs, Jerusalem, Israel). After washing, bound antibody was revealed with
HRP-conjugated goat anti-rabbit IgG antibody (1/10000, Jackson Immuno-
search Laboratories, Westgrove, PA) in blocking buffer for 30 min, followed
by visualization with the ECLPlus detection system (Amersham Bioscien-
ces) according to manufacturer’s instructions. Immunoblots were exposed
on hyperﬁlm ECL (Amersham Biosciences).
Real-time RT-PCR
Tissues were isolated from 3-week-old female NMRI mice, 14-day-old
embryo Swiss Webster mice (Ambion, Austin, TX), CHO-K1 cells, unstim-
ulated and stimulated human CD4 positive T-lymphocytes prepared as
previously described (Nielsen et al., 1996) (gift from N. Ødum), and total
RNA extracted by the RNAqueous-Midi kit (Ambion) according to
the manufacturer’s instructions. To avoid DNA contamination, the obtained
RNA was treated with DNaseI followed by phenol/chloroform extraction.
cDNA synthesis was performed with M-MLV reverse transcriptase
(Promega) with a random hexanucleotide, according to the manufacturer’s
instructions. The chosen PCR primers give rise to fragments around 300 bp
for mKCNE4, hKCNE4, mGADPH, and hGADPH. The real-time PCR was
performed on a DNA Engine Opticon TM machine from MJ Research
with the Opticon Monitor software. SYBR Green PCR Master Mix
(Applied Biosystems) was used, and the reactions were performed under the
following conditions: 958C for 30 s, 668C for 15 s, and 728C for 1 min,
preceded by 5 min at 958C and followed by 5 min at 728C. Melting curves
were performed after each reaction to verify the speciﬁcity of the product. As
variations in cDNA quality within the different samples may occur, GADPH
was included as an internal reference. By subtracting the GADPH CP
(crossing point) value from the KCNE4 CP value of each sample, the cDNA
quality of each sample is taken into account (Livak and Schmittgen, 2001).
The relative quantiﬁcation of the mRNA levels in each individual sample
was done according to the model suggested by M. Pfafﬂ (Pfafﬂ, 2001). For
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each primer set a standard curve was made and the slope factor calculated.
The corresponding real-time PCR efﬁciency (E) of one cycle in the
exponential phase was calculated according to the equation: E¼ 10(1/slope).
The relative KCNE4 ratios were calculated according to the following
equation: ratio ¼ EDCP(control  sample).
RESULTS
KCNE4 inhibits Kv1.1 and Kv1.3 channels
To investigate if KCNE4-subunits could affect the gating of
Kv channels, Kv1.1 and Kv1.3 channels alone or together
with the KCNE4-subunit were expressed in oocytes from
Xenopus laevis and two-electrode voltage-clamp recordings
were performed (Fig. 1). As expected, Kv1.1- and Kv1.3-
expressing oocytes showed fast activating and slowly
inactivating voltage dependent currents, which were acti-
vated at potentials more positive than 50 mV (Fig. 1 A).
Coexpression of KCNE4 with either Kv1.1 or Kv1.3 resulted
in a dramatic reduction of the speciﬁc Kv current to levels
between a 10-fold decrease and a complete inhibition. In
experiments where a very reduced Kv1.1 or Kv1.3 current
could be detected, no change in the kinetics could be
observed compared to Kv1.1 or Kv1.3 channels expressed
in the absence of KCNE4. The average maximal current
measured at 160 mV was determined to 28.1 6 2.1 mA
(n ¼ 20) for Kv1.1 alone and to 2.3 6 0.5 mA (n ¼ 16)
for Kv1.1 1 KCNE4 (p\0.0001). For Kv1.3 and Kv1.3 1
KCNE4 the current was measured to be 12.96 1.2 mA (n ¼
50) and 0.4 6 0.1 mA (n ¼ 33), respectively ( p\ 0.0001,
illustrated in Fig. 1 B).
Potential interactions between other KCNE-subunits and
Kv1.1 or Kv1.3 were also investigated in the oocyte
expression system. We did not observe any effect of
KCNE1, KCNE2, or KCNE3 on Kv1.1 channels expressed
in oocytes (n ¼ 5, data not shown). Nor did we detect any
effect of KCNE1 or KCNE2 on Kv1.3 (n ¼ 5, data not
shown), which, with respect to KCNE2, has been reported
previously (Abbott et al., 1999). For unknown reasons
coinjection of Kv1.3 and KCNE3 cRNA killed the oocytes
shortly after injection, and electrophysiological experiments
have therefore not been performed with this combination. A
similar observation has been reported for KCNQ1/KCNE5-
injected oocytes (Angelo et al., 2002).
To exclude the possibility that the inhibition by the
KCNE4-subunit could be an artifact of the oocyte expression
system, we performed whole-cell electrophysiology on
HEK293 cells expressing Kv1.1 or Kv1.3 alone or
expressing Kv1.1 or Kv1.3 together with KCNE4 (Fig. 2).
Expression of both a- and b-subunits in the same cell is
ensured by usage of a bicistronic vector where Kv1
translation is initiated after an internal ribosome entry site
from EMCV (see Methods). As observed in oocytes, Kv1.1-
FIGURE 1 KCNE4 inhibits Kv1.1 and Kv1.3 currents in Xenopus laevis
oocytes. (A) Current traces (left side) and averaged IV-curves (right side)
obtained in oocytes expressing Kv1.1 or Kv1.3 alone or together with
KCNE4. Oocytes were clamped at 80 mV for 3 s, current traces were
elicited by 2-s voltage steps to potentials ranging from100 mV to160 mV
in 20 mV increments, and tail currents were recorded at 30 mV (see
inserted protocol). Oocytes expressing only Kv1.1 or Kv1.3 channels
responded to this voltage protocol with a fast-activating and a slow-
inactivating current. For oocytes coinjected with KCNE4, a drastic reduction
in the overall current level was observed. (B) Mean current values of oocytes
expressing either Kv1.1 or Kv1.3 alone or together with KCNE4. Peak
current values were measured at160 mV. For Kv1.1 and Kv1.1/KCNE4, an
average current level of 28.16 2.1 mA (n¼ 20) and 2.36 0.5 mA (n¼ 16),
respectively, was found. A similar drastic reduction in the overall current
level was observed for Kv1.3 and Kv1.3/KCNE4 with values of 12.9 6 1.2
mA (n ¼ 50) and 0.4 6 0.1 mA (n ¼ 33), respectively.
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and Kv1.3-expressing HEK293 cells showed fast activating
and slowly inactivating voltage-dependent currents, which
activated at potentials more positive than50 mV (Fig. 2 A).
Similarly, KCNE4 was capable of signiﬁcantly reducing the
current amplitude of both Kv1.1 and Kv1.3, although in a less
drastic manner for Kv1.1 (Fig. 2 B). The average maximal
current density measured at 160 mV was 195 6 39 pA/pF
(n ¼ 18) for Kv1.1 alone and 75 6 17 pA/pF (n ¼ 19) for
Kv1.1 1 KCNE4 ( p \ 0.01). For Kv1.3 and Kv1.3 1
KCNE4 the current density was determined to be 91 6 21
pA/pF (n¼ 9) and 136 4 pA/pF (n¼ 12), respectively ( p\
0.001).
Speciﬁcity of the KCNE4 inhibition among
Kv channels
An important question is whether the inhibition by KCNE4
is a common phenomenon for Kv channels. To address this
problem, Kv1.2, Kv1.4, Kv1.5, and Kv4.3 channels were
expressed either alone or together with KCNE4 in the
Xenopus oocytes. As demonstrated in Fig. 3, no signiﬁcant
alterations in kinetics or current amplitude were observed for
Kv1.2, Kv1.4, Kv1.5, and Kv4.3 coexpressed with KCNE4
as compared to controls. The maximal current density
measured at160 mV was, for Kv1.2 alone, 1.716 0.14 mA
(n ¼ 16); for Kv1.2/KCNE4, 1.53 6 0.19 mA (n ¼ 11); for
Kv1.4, 1.266 0.30 mA (n¼ 16); for Kv1.4/KCNE4, 1.616
0.33 mA (n¼ 8); for Kv1.5 alone, 26.16 8.4 mA (n¼ 3); for
Kv1.5/KCNE4, 19.8 6 2.3 mA (n ¼ 5); for Kv4.3 alone,
26.4 6 2.4 mA (n ¼ 3); and for Kv4.3/KCNE4, 24.8 6 2.0
mA (n ¼ 3).
KCNE4 inhibition of heteromeric Kv1 channels
As Kv1 a-subunits both in vitro and in vivo are known to
assemble into heteromeric complexes, we were interested in
analyzing the effect of KCNE4 on channel complexes
containing Kv1.1- or Kv1.3-subunits (Fig. 4). At least in
mammalian brain, the most abundant Kv1 a-subunits are
Kv1.1 and Kv1.2, and all heteromeric Kv1 channels contain
either one or both of these subunits (Koch et al., 1997;
Koschak et al., 1998). Different combinations of Kv1.1,
Kv1.2, and Kv1.3 (Kv1.1/Kv1.2, Kv1.1/Kv1.3 and Kv1.2/
Kv1.3) were injected in ratios calculated to obtain 50%
contribution of each subunit to the overall current amplitude.
To conﬁrm the existence of heteromeric channel complexes,
the following experiments were conducted. First, charybdo-
toxin (ChTX) was applied as a pharmacological tool to
separate Kv1.1 and Kv1.2 currents. As previously reported,
ChTX did not inhibit homomeric Kv1.1 channels in
concentrations up to 30 nM (data not shown), whereas we
found Kv1.2 channels to be blocked by ChTX with an IC50
FIGURE 2 KCNE4 inhibits Kv1.1 and Kv1.3 currents in HEK293 cells.
(A) Current traces from whole-cell recordings (left side) and averaged IV-
curves (right side) for HEK293 cells expressing Kv1.1 or Kv1.3 alone or
together with KCNE4. Transfected cells were clamped at 80 mV for 3 s,
current traces were elicited by 2-s voltage steps to potentials ranging from
100 mV to160 mV in 20-mV increments, and tail currents were recorded
at 30 mV (see inserted protocol). Cells expressing Kv1.1 and Kv1.3
channels responded to this voltage protocol with a fast-activating and a slow-
inactivating current. For cells expressing KCNE4 together with Kv1.1 or
Kv1.3 a-subunits, a signiﬁcant reduction in the overall current level was
observed. (B) Mean current values of HEK293 cells expressing either Kv1.1
or Kv1.3 alone or together with KCNE4. Peak current values were measured
at160 mV. For Kv1.1 and Kv1.1/KCNE4 an average current density of 195
6 39 pA/pF (n¼ 18) and 756 17 pA/pF (n¼ 19), respectively, was found.
An even more pronounced reduction in the overall current level was
observed for Kv1.3 and Kv1.3/KCNE4 with values of 91 6 21 pA/pF (n ¼
9) and 13 6 4 pA/pF (n ¼ 12), respectively.
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of 1.7 6 1.9 nM (n ¼ 4), which is in the same range as
previously reported (Grissmer et al., 1994). When ChTX was
added to oocytes coexpressing functionally equal amounts of
Kv1.1 and Kv1.2, it was found that around 85% of the
overall current could be blocked with 30 nM ChTX (Fig.
4 C). A complete random assembly of Kv1.1- and Kv1.2-
subunits into functional channels would imply that 6.25% of
all channels should be homomeric Kv1.1, another 6.25%
homomeric Kv1.2 channels, whereas the remaining com-
FIGURE 3 KCNE4 does not inhibit Kv1.2, Kv1.4, Kv1.5, or Kv4.3.
Current traces from oocytes expressing Kv1.2, Kv1.4, Kv1.5, and Kv4.3
alone or together with KCNE4. Oocytes were clamped at 80 mV for 3 s,
current traces were elicited by 2-s voltage steps to potentials ranging from
100 mV to160 mV in 20-mV increments, and tail currents were recorded
at 30 mV. Oocytes expressing Kv channels responded to this voltage
protocol with a fast activation and a slow (Kv1.2, Kv1.5) or fast (Kv1.4,
Kv4.3) inactivation. No difference in kinetics or current amplitude was
found for oocytes coinjected with KCNE4 cRNA. Mean current values
(measured at 160 mV) of oocytes expressing either Kv1 channels alone or
together with KCNE4 were as follows: 1.716 0.14 mA (n ¼ 16) for Kv1.2;
1.53 6 0.19 mA (n ¼ 11) for Kv1.2/KCNE4; 1.26 6 0.30 mA (n ¼ 16) for
Kv1.4; 1.61 6 0.33 mA (n ¼ 8) for Kv1.4/KCNE4; 26.1 6 8.4 mA (n ¼ 3)
for Kv1.5; 19.86 2.3 mA (n¼ 5) for Kv1.5/KCNE4; 26.46 2.4 mA (n¼ 3)
for Kv4.3; and 24.8 6 2.0 mA (n ¼ 3) for Kv4.3/KCNE4.
FIGURE 4 KCNE4 inhibition of heteromeric Kv1 channels. (A) Current
traces from oocytes expressing Kv1.1/Kv1.2, Kv1.1/Kv1.3, and Kv1.2/
Kv1.3 channels alone or together with KCNE4. Oocytes were clamped at
80 mV for 3 s, current traces were elicited by 2-s voltage steps for
potentials ranging from 80 mV to 140 mV in 20-mV increments, and tail
currents were recorded at 30 mV. (B) Mean current values of oocytes
expressing Kv1 channels alone or of oocytes expressing Kv1 channels
together with KCNE4. Peak current values, measured at 140 mV, were as
follows: 26.16 1.9 mA (n ¼ 24) for Kv1.1/Kv1.2; 12.76 1.7 mA (n ¼ 24)
for Kv1.1/Kv1.2/KCNE4; 21.9 6 2.1 mA (n ¼ 8) for Kv1.1/1.3; 2.5 6 1.6
mA (n ¼ 4) for Kv1.1/Kv1.3/KCNE4; 6.70 6 0.70 mA (n ¼ 11) for Kv1.2/
Kv1.3; and 1.45 6 0.30 mA (n ¼ 12) for Kv1.2/Kv1.3/KCNE4. (C) Dose-
response curve of charybdotoxin (ChTX) on Kv1.2- and Kv1.1/Kv1.2-
expressing oocytes. Currents were measured at160 mV. All data points are
an average of four recordings on independent oocytes. (D) Current level of
Kv1.2 and Kv1.2/Kv1.1SYG expressing oocytes measured at 160 mV.
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plexes should consist of heteromeric Kv1.1/1.2 channels in
different stoichiometry. These results obtained by ChTX
inhibition thereby talks in favor of a small subpopulation of
homomeric Kv1.1 channels that are insensitive to ChTX,
whereas the remaining channels are made up of pre-
dominantly heteromeric Kv1.1/1.2 complexes and a small
fraction of Kv1.2 homomeric channels that are all sensitive
to ChTX. It could be argued that all ChTX-sensitive current
originates from homomeric Kv1.2 channels, but if this was
true it should be expected that the Kv1.1/1.2 dose-response
curve was rightward-shifted compared to the Kv1.2 curve,
due to the presence of some homomeric Kv1.1 channels.
This is not observed, again indicating the presence of
heteromeric Kv1.1/1.2 complexes.
Second, to analyze the potential complex formation
between Kv1.1 and Kv1.2, a nonconducting dominant
negative Kv1.1 mutant (Kv1.1SYG) was applied (Wollnik
et al., 1997). Coexpression of Kv1.1SYG together with
Kv1.2 resulted in a 10-fold current reduction as compared
to the current obtained with Kv1.2 alone (4.51 6 0.89 mA
(n ¼ 8) for Kv1.2 versus 0.43 6 0.13 mA (n ¼ 8) for
Kv1.2/Kv1.1SYG) (Fig. 4 D). As for the ChTX experiments,
this points toward formation of heteromeric Kv1.1/1.2 chan-
nels. Thereby, these experiments indicate expression of
Kv1.1- and Kv1.2-subunits at a comparable level as well
as heteromeric channel complex formation as reported by
others (Isacoff et al., 1990; Ruppersberg et al., 1990; Christie
et al., 1990). When KCNE4 was expressed together with
either combination of the two a-subunits, a signiﬁcant
current reduction was observed. A current reduction of more
than 50% was seen when KCNE4 was coexpressed with
Kv1.1/ Kv1.2 (12.7 6 1.7 mA, n ¼ 24) as compared to
control levels (26.1 6 1.9 mA, n ¼ 24)( p\ 0.0001, Fig.
4 B). As would be expected, oocytes expressing Kv1.1/
Kv1.3/KCNE4 had a drastic reduction in current level (2.56
1.6 mA, n ¼ 4) compared to oocytes expressing only Kv1.1/
Kv1.3 (21.96 2.1 mA, n¼ 8) ( p\0.0001)(Fig. 4 B). When
KCNE4 was expressed together with Kv1.2/Kv1.3, an
almost ﬁvefold reduction in the current level was found
(1.45 6 0.30 mA, n ¼ 12) as compared to control oocytes
expressing only Kv1.2/Kv1.3. (6.70 6 0.70 mA, n ¼ 11)
( p\ 0.0001).
Kv1.1 and Kv1.3 currents are modiﬁed by
delayed injection of KCNE4 cRNA
Having established the speciﬁc inhibitory property of
KCNE4 on Kv1.1 and Kv1.3 channels, a more detailed
investigation of the KCNE4 inhibitory mechanism was
performed. For other Kv-interacting b-subunits, it has
been demonstrated that simultaneous translation of a- and
b-subunits is necessary for the ability of the b-subunit to
exert its effect on the a-subunit, indicating an interaction
early in biosynthesis (Fink et al., 1996; Shi et al., 1996). To
examine if this was true also for the inhibitory effect of
KCNE4, we performed experiments with delayed injection
of KCNE4 cRNA into oocytes already expressing Kv1.1 or
Kv1.3 (Fig. 5). Fig. 5 A illustrates the current levels as a
function of time in oocytes initially injected with Kv1.3
cRNA at time point 0. At 28 h later, when a current level of
6.6 6 0.7 mA was reached, these oocytes were reinjected
with either KCNE4 cRNA or H2O. At 32 h after the delayed
injection, a complete block of the Kv1.3 current by KCNE4
was observed. At the same time point (60 h), Kv1.3-
expressing oocytes, which had been reinjected with H2O,
FIGURE 5 Kv current can be modiﬁed by delayed injection of KCNE4.
(A) Oocytes injected with Kv1.3 cRNA were incubated 28 h, which resulted
in a current level of 6.7 6 0.7 mA recorded at 1608mV. The oocytes were
then separated in two pools and subsequently injected with either H2O ( ﬁlled
squares) or KCNE4 cRNA ( ﬁlled triangles). Injection of KCNE4 resulted in
a complete inhibition of the Kv1.3 current, whereas H2O-injected oocytes
continued to express Kv1.3 current. Control oocytes injected with both
Kv1.3 and KCNE4 cRNA at time 0 (open squares) did not at any time
provide Kv1.3 speciﬁc current. (B and C) To obtain a higher time resolution
for the inhibitory property of KCNE4, oocytes expressing either Kv1.1 or
Kv1.3 channels were injected with KCNE4 cRNA 72 h after Kv injection
(time 0 at graph). Expression levels of Kv current were subsequently
followed every third hour. For both Kv1.1- and Kv1.3-expressing oocytes,
a complete inhibition of the current could be observed within 24 h. All data
points are an average of four recordings on independent oocytes.
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showed an almost twofold increase in the current level (11.6
6 4.1 mA), which subsequently slowly declined until the end
of the experiment after 164 h. The current in oocytes, in
which the Kv1.3 channel had been blocked by delayed
injection of KCNE4 or in which the channels were blocked
by initial coexpression of KCNE4, remained blocked
throughout the rest of the experiments (up to 100 h). As it
may be speculated that injection of nonspeciﬁc cRNA can
have an effect on the Kv1 current level, we injected KCNE2
cRNA into oocytes already expressing Kv1 channels. These
oocytes showed a similar response as water-injected oocytes
(data not shown).
To obtain a higher time resolution of the ability of KCNE4
to inhibit Kv1.1 or Kv1.3 channels, additional delayed
injecting experiments were performed (Fig. 5 B and Fig. 5C).
After 72 h when a current level of 11.0 6 0.3 mA (Kv1.1)
and 11.5 6 4.0 mA (Kv1.3) was obtained (time 0 at graph),
a fraction of the expressing oocytes was injected with
KCNE4 cRNA. These experiments showed a signiﬁcant
reduction in the Kv1.1 and Kv1.3 current level within a few
hours after delayed injection and a complete inhibition after
24 h. The results shown in Fig. 5 indicate a KCNE4 in-
hibitory mechanism on Kv1.1 and Kv1.3 channels similar to
the mechanism we previously have reported on KCNQ1
where KCNE4 blocked KCNQ1 current within 24 h of
delayed injection (Grunnet et al., 2002a).
Membrane expression of Kv1.1 is unaltered
in the presence of KCNE4
The results displayed in Fig. 5 leave some unanswered
questions considering the mechanism of KCNE4 inhibition.
It could be speculated that KCNE4 has the ability to
withdraw functional Kv1 channels from the plasma mem-
brane, or that a direct interaction in the plasma membrane
or earlier in the translocation pathway is responsible for
the inhibition. For KCNQ1 we previously observed that
KCNE4-subunits do not alter the total amount of KCNQ1
proteins at the cell surface, demonstrating that the inhibition
of KCNQ1 by KCNE4 takes place in the plasma membrane
(Grunnet et al., 2002a). To analyze if KCNE4 also interacts
with Kv1.1 in the plasma membrane, immunocytochemistry
was performed on transiently transfected HEK293 cells. The
cells were cotransfected with Kv1.1 or Kv1.1/KCNE4-
c-myc, stained with antibodies raised against Kv1.1 channels
and the c-myc epitop, and detected by confocal microscopy
(Fig. 6). The functionality of the KCNE4 protein with a
c-myc tag in the C-terminal tail was conﬁrmed in the oocyte
system, where no difference between wild-type and c-myc-
tagged subunits was found (data not shown). Kv1.1 and
KCNE4-c-myc protein could be detected both intracellularly
and in what appears to be the plasma membrane, and the
amount of Kv1.1 channels in the plasma membrane appeared
to be the same both in the presence and absence of KCNE4
(Fig. 6, A1 and B). A relatively low amount of Kv1.1 proteins
in the membrane is to be expected as Manganas and Trimmer
(2000) previously showed that when Kv1.1 is expressed
alone, a low percentage of the channels are found at the cell
surface. When the staining pattern of Kv1.1 (Fig. 6 A1) and
KCNE4-c-myc (Fig. 6 A2) were superimposed, a partly
overlapping localization both in the membrane area and
intracellular compartments could be detected (Fig. 6 A3).
FIGURE 6 Kv1.1 and KCNE4 colocalize in the cell membrane. Confocal
scans of a HEK293 cell transfected with Kv1.1/ KCNE4-c-cmyc (A) and
Kv1.1 (B). After ﬁxation the cells were labeled with anti-Kv1.1 antibody (A1
and B) and anti-c-myc antibody (A2). (A3) represents an overlay of the two
labelings. For both proteins, large amounts of intracellular labeling were
observed. However, some labeling could be detected in what appeared to be
the plasma membrane (arrow). In many cases the pattern of staining of the
two proteins overlapped (arrow). Scale bar 8 mm.
FIGURE 7 KCNE4 does not hinder expression of Kv1.1 at the cell
surface. (A) Western blot, stained with Kv1.1 antibody, of biotinylated
surface proteins from oocytes expressing Kv1.1 or Kv1.1/KCNE4. (B)
Western blot, stained with Kv1.1 antibody, of total protein and biotinylated
surface proteins from HEK293 cells expressing Kv1.1, Kv1.1/KCNE4, and
pXOOM (control). Expression of both Kv1.1 and KCNE4 in all transfected
cells was obtained by usage of a bicistronic construct (see Methods). Kv1.1
was expressed at comparable levels in the plasma membrane in the absence
and presence of KCNE4. 1 and  indicate the presence or absence of
KCNE4 protein, respectively. Biotin indicates the loading of biotinylated
proteins, whereas total indicates that total cell lysates were loaded.
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To conﬁrm that Kv1.1 protein is located in the membrane
when KCNE4-subunits are present, we performed Western
blotting of membranes from oocytes and of HEK293 cells
expressing Kv1.1, Kv1.1/KCNE4, and control plasmids
(Fig. 7). Fig. 7 A is a Western blot of surface proteins from
oocytes expressing Kv1.1 or Kv1.1/KCNE4. To obtain
highly puriﬁed membranes, oocytes were initially biotiny-
lated and membranes subsequently isolated by differential
centrifugation. Finally, this membrane fraction was further
puriﬁed by streptavidin-coupled agarose absorption. The
Kv1.1 antibody detects a band of ;60 kDa which
corresponds with the previous reported size of the Kv1.1
protein obtained from cultured cells (Manganas and
Trimmer, 2000). Whether KCNE4 is present or absent in
the oocytes does not affect the surface expression level of
Kv1.1, as comparable band intensities were detected in both
cases. A similar result was obtained with Western blotting of
biotinylated surface proteins from HEK293 cells expressing
Kv1.1 or Kv1.1/KCNE4 (Fig. 7 B). Clear bands of;60 kDa
were detected in both lanes of biotinylated surface proteins.
As a control of the transfection efﬁciency, total protein from
cells transfected with either Kv1.1 alone or KCNE4/Kv1.1
were analyzed. Comparable staining intensities were found,
indicating that equal amounts of Kv1.1 protein were present
in the cell-surface- and in the total-cell-preparation of cells
expressing Kv1.1 and Kv1.1/KCNE4. In summary, the
Western blotting and confocal microscopy demonstrate that
KCNE4 does not alter the subcellular distribution of Kv1.1.
Tissue quantiﬁcation of KCNE4 mRNA levels
Kv1.1 and Kv1.3 are expressed in several organs and tissues.
Therefore, to illuminate where a potential interaction
between Kv1.1/Kv1.3 and KCNE4-subunits may take place
in vivo, we performed real-time RT-PCR of KCNE4 on
RNA obtained from a number of tissues (Table 1). Double-
stranded DNA products were detected by the SYBR green
ﬂuorophore, and GADPH was used as an internal reference.
The relative mKCNE4 mRNA expression level was nor-
malized according to uterus tissue, which is the tissue with
the highest expression level. Compared to uterus tissue, a
relatively high expression level in embryo, lung, small
intestine, colon, and kidney tissue was found by real-time
RT-PCR. These results correspond well with the results we
have previously obtained by RT-PCR (Grunnet et al.,
2002a). In heart and brain tissue we detected ;1% of the
KCNE4 mRNA found in uterus tissue. When the brain was
separated into different parts, a 1% expression level is also
observed in the cerebellum, whereas a lower expression level
was observed in the hippocampus, cortex, hypothalamus,
and medulla spinalis. As the Kv1.3 channel is an important
component in the maturation of T-lymphocytes (Grissmer
et al., 1990), unstimulated and stimulated human T-lym-
phocytes were also tested for KCNE4 expression. No
signiﬁcant difference in KCNE4 expression was observed
between unstimulated and stimulated T-cells, indicating
that KCNE4 does not play a role in maturation of T-lym-
phocytes.
DISCUSSION
In the present study we have shown that KCNE4 drastically
inhibits Kv1.1 and Kv1.3 currents independently of the
applied expression system. In Xenopus oocytes a more than
TABLE 1 KCNE4 mRNA expression in mouse tissues and human T-cells.
Tissue CP(KCNE4) (Mean 6 SD) CP(GADPH) (Mean 6 SD) CP(KCNE4) – CP(GADPH)
Normalized (KCNE4)
(relative to uterus)
Brain 28.6 6 0.4 20.2 6 0.7 8.4 6 0.9 0.01
Cerebellum 31.8 6 0.5 20.9 6 1.1 10.9 6 1.2 0.01
Hippocampus 32.9 6 0.5 21.3 6 0.9 11.6 6 1.0 0.0004
Cortex 32.4 6 0.8 21.1 6 0.8 11.2 6 1.1 0.0006
Hypothalamus 31.2 6 0.5 20.8 6 0.8 10.4 6 0.9 0.001
Medulla spinalis 31.9 6 0.4 20.8 6 0.9 11.1 6 1.0 0.0007
Uterus 26.3 6 0.3 23.5 6 1.0 2.8 6 1.1 1
Kidney 26.8 6 0.1 20.9 6 0.8 5.9 6 0.8 0.11
Lung 29.6 6 0.3 25.0 6 1.1 4.7 6 1.1 0.30
Colon 28.4 6 0.09 22.8 6 0.8 5.6 6 0.8 0.15
Small intestine 28.0 6 0.3 22.4 6 1.1 5.6 6 1.1 0.15
Heart 28.3 6 0.08 19.8 6 0.9 8.5 6 0.9 0.009
Embryo 26.9 6 0.4 22.7 6 0.9 4.3 6 1.0 0.60
CHO-K1 [45 32.0 6 1.5 [13 \0.0001
T-lymphocytes
Unstimulated 30.6 6 0.3 21.2 6 0.2 9.4 6 0.4 nd
Stimulated 30.5 6 0.3 21.9 6 0.6 8.6 6 0.6 nd
Real-time RT-PCR analyses of total RNA extracted from NMRI mice tissue, 14-day-old-embryo Swiss Webster mice (Ambion), CHO-K1 cells, and human
T-lymphocytes. CP (crossing point) is the PCR-cycle number where a 0.01 ﬂuorescent signal is detected (Opticon Monitor software). nd, not done.
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10-fold reduction and in HEK293 cells a 2.5-fold (Kv1.1)
and a 7-fold (Kv1.3) reduction in the current amplitude was
found. For most potassium channel b-subunits described
until now, either a change in kinetics or an enhanced surface
expression has been observed (Rettig et al., 1994; Shi et al.,
1996; Barhanin et al., 1996; Sanguinetti et al., 1996; Abbott
et al., 2001). However, we have recently shown that KCNE4
inhibits KCNQ1 current in both oocytes and mammalian
cells, whereas others have reported that ERG1 and KCNQ4
currents are inhibited by KCNE3 in oocytes and that KCNE2
reduces KCNQ1 current in mammalian cells (Grunnet et al.,
2002a; Tinel et al., 2000a; Schroeder et al., 2000).
It should be kept in mind that the choice of expression
system for the coexpression of a- and b-subunits may
seriously interfere with the results of experiments. For
example, it has been described that KCNE2 does not affect
KCNQ1 gating when coexpressed in oocytes, although
KCNE2 apparently is associated with the KCNQ1 channel
complex (Tapper and George, 2000; Abbott et al., 1999).
To the contrary, coexpression of KCNE2 and KCNQ1 in
mammalian cells resulted in a dramatic shift in the voltage-
sensitivity of the KCNQ1 channels (Tinel et al., 2000a;
Abbott et al., 1999). Until recently expression in both
oocytes and mammalian cells suggested KCNE2 and
hERG1 as the molecular component behind the cardiac
Ikr current (Abbott et al., 1999; Isbrandt et al., 2002; Cui
et al., 2001). However, this notion has now been challenged
by the fact that KCNE2 and hERG1 expressed in
mammalian cells might not recapitulate the native Ikr
current (Weerapura et al., 2002). The fact that our
experiments show that the inhibitory effect of KCNE4 on
Kv1.1 and Kv1.3 channels is found after coexpression in
oocytes as well as in mammalian cells suggests that this
effect of KCNE4 may also be found in native cells, where
KCNE4 b-subunits may be colocalized with voltage-
regulated potassium channels of the Kv type.
The KCNE4 inhibition is not a general phenomenon
among Kv channels, as KCNE4 proteins do not affect the
kinetics or current levels of Kv1.2, Kv1.4, Kv1.5, or Kv4.3.
In vivo Kv1 channels are often found to be heteromeric
complexes in which up to four different Kv1-subunits form
the functional channel (Shamotienko et al., 1997). As Kv1.2
is one of the major components in Kv1 heteromeric
complexes, we coinjected Kv1.2 with either Kv1.1 or
Kv1.3 into oocytes to analyze if KCNE4-subunits inhibit
these heteromeric channels. When KCNE4 was expressed
together with these complexes, a twofold and a ﬁvefold
reduction in the current level was observed for Kv1.1/Kv1.2
and for Kv1.2/Kv1.3 complexes, respectively. These results
indicate that KCNE4 proteins somehow interact with Kv1.1-
and Kv1.3-subunits present in the heteromeric complexes
and thereby modulate the entire Kv1 channel complex.
KCNE4 has an overall 25–30% peptide sequence identity
to KCNE1-3,5 and in the proposed transmembrane regions
there is a 60–70% similarity between KCNE4 and the other
KCNEs. For KCNE1, the transmembrane region has been
shown to interact directly with the a-subunit (KCNQ1), and
both the transmembrane segment and the C-terminal are
responsible for modulation of kinetics (Romey et al., 1997;
Tai and Goldstein, 1998; Tapper and George, 2000).
Whether it is the transmembrane segment or other parts of
the KCNE4 protein that is responsible for the interaction and
modulation of Kv1.1/Kv1.3 and KCNQ1 channels is
unknown. Abbott and Goldstein showed through mutant
studies that similar mutations within the KCNE1,2,3-
subunits result in modulation of three different a-subunits
in a comparable manner (Abbott and Goldstein, 2002). This
indicates that KCNEs interact by a similar mechanism with
different a-subunits, which may explain why KCNE4 can
inhibit such relatively different proteins as Kv1 and KCNQ1
channels (Grunnet et al., 2002a).
The mechanism behind KCNE4 and Kv1.1/Kv1.3 inter-
actions was examined in a number of experiments. Western
blotting and confocal microscopy showed that the cellular
distribution of Kv1.1 and KCNE4 proteins was unchanged,
even though either no current or a very reduced current could
be detected, as compared to cells expressing only Kv1.1.
This indicates that KCNE4 inhibition of Kv1.1/Kv1.3 is not
due to an effect on the translation machinery or the transport
pathway but rather caused by a direct effect on the gating of
channels located in the cell surface membrane. However, this
is only a proposition, as we cannot conclude from the
conducted experiments that KCNE4 interacts directly with
the channel complexes in the membrane. KCNE4 modula-
tion of channel complexes already present in the cells opens
up for the interesting aspect that KCNE4-subunits under
certain conditions could be expressed and interact with
Kv1.1 and Kv1.3 channels. Indeed, delayed injection ex-
periments demonstrated that currents generated by Kv1.1
and Kv1.3 channels can be almost completely inhibited by
KCNE4-subunits within 24 h of injection.
Since Kv1 potassium channels are expressed both in the
brain and inmany peripheral tissues, a subunit with inhibitory
properties such as KCNE4 will potentially have a signiﬁcant
impact onmembrane potential inmany cell types. In excitable
tissue such an effect would mean a general increase in cellular
excitability asKv1 channels normally reduce the ﬁring rate. In
other cell types, such as epithelia, the ability of these channels
to perform transepithelial transport could be affected by
KCNE4 expression. This potential of KCNE4-subunits will
depend on colocalization of KCNE4 and Kv1.1 or Kv1.3. By
real-time RT-PCR, a relatively high expression level of
mKCNE4mRNAwas detected in uterus, kidney, lung, colon,
and 14-day-old embryo. Lower expression level was found in
heart, total-brain, and ﬁve different brain parts. These results
ﬁt very well with previous results generated by semi-
quantative RT-PCR (Grunnet et al., 2002a). The tissue
distribution described above indicates that the functional role
of KCNE4 may be found in epithelial tissues. Kv1 proteins
have been described in several tissues in which we detect
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KCNE4 mRNA, such as lung, kidney, colon and uterus, but
the exact location and function of the putative interaction
cannot be concluded from this study.
As Kv1.1/Kv1.3 and KCNE4 may be coexpressed in
several different cell types, it can be speculated that KCNE4
participates in a subacute (i.e., within hours) regulation of
cellular functions by modulating the Kv1 current. What
triggers the expression of KCNE4 is an open question, but
hormones could be potential candidates. The time frame of
the KCNE4 modulatory effect on Kv1.1/Kv1.3 channels is
comparable to the time frame observed for proteins regulated
by hormones, and, indeed, another member of the KCNE
family, namely KCNE1, has been found to be regulated by
hormones (Felipe et al., 1994). The function of KCNE4
could thereby be to down-regulate the conductance of Kv1.1/
Kv1.3 channels already present in the cell surface.
We have previously reported that KCNQ1 is inhibited by
KCNE4 (Grunnet et al., 2002a). The KCNE4 inhibition of
KCNQ1 is comparable to the presented inhibition of Kv1.1/
Kv1.3. For several of the other KCNE-subunits it has, as
mentioned earlier, been shown that they may interact with
more than one a-subunit family. b-subunits having more
than one a-subunit partner give the possibility of having
a very complex regulation of ion channels on the cellular
level with a relatively low number of genes.
In summary, the results in this paper demonstrate the
ability of KCNE4 to severely inhibit certain types of Kv1
channels. The growing number of reports showing in-
teractions between KCNE proteins and different types
of potassium channels points to this family of regulatory
b-subunits as very important in a number of different
physiological functions. However, the exact physiological
function of the KCNE4 and Kv1.1/Kv1.3 interaction has to
be elaborated in future studies.
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